{"name":"Shirley Ryan AbilityLab","slug":"shirley-ryan-abilitylab","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Gralise","genericName":"Gralise","slug":"gralise","indication":"Other","status":"marketed"}]},{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"5-Azacitidine","genericName":"5-Azacitidine","slug":"5-azacitidine","indication":"Acute myeloid leukemia","status":"phase_2"}]},{"name":"Pain","slug":"pain","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"cardiovascular","drugs":[{"name":"Hydromorphone ER","genericName":"Hydromorphone ER","slug":"hydromorphone-er","indication":"Chronic pain requiring continuous opioid therapy","status":"marketed"}]}],"pipeline":[{"name":"Gralise","genericName":"Gralise","slug":"gralise","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"5-Azacitidine","genericName":"5-Azacitidine","slug":"5-azacitidine","phase":"phase_2","mechanism":"Inhibits DNA methyltransferase","indications":["Acute myeloid leukemia"],"catalyst":""},{"name":"Hydromorphone ER","genericName":"Hydromorphone ER","slug":"hydromorphone-er","phase":"marketed","mechanism":"Hydromorphone ER is an opioid agonist that binds to mu-opioid receptors in the central nervous system to produce analgesia and pain relief.","indications":["Chronic pain requiring continuous opioid therapy","Moderate to severe pain in opioid-tolerant patients"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxQZERYZ1ZobDlWWG15RUZGYVFGSGRlR2ZRZVhWMGItOHN5eGw0MEROYVlCWXprd0JGLVVYYVdCQzVrZGNoajhNLVpSSnpnYTd5dmhCc0U0VWtKZ0VweTdLVnQ1UnExbEFaQzFuRFBFbmY2X29wZXR4WHJwYVJrN09KT2hweVl2Y2JGX29jTjNqZ0FkVXpMSGlHUjdjWVQ1X19XMkhmLUpwX2dRaEZ10gGyAUFVX3lxTE1lNkpQODJMNkFjdDlwYVI5Z3BsZjQyRzhjaVhuc0ZkNTd0ejhxTUZIZjJIS0UzdkZ5Tm9ZaGhiUk56N0tKTkdpWG9pUmdNMnR5czVBNHdjYlpualYwRnBTU2l0ay1NSDBuUkk2S1VsWGR0My1yNy13MF9YNUpXaEhwSXZyNEpUSUFKcVpTMmtha1JISE9uNjctSnpGYURvWThiWlYxVlhOOVlkUzlQSTVqVnc?oc=5","date":"2026-02-05","type":"pipeline","source":"WGN-TV","summary":"New drug may help spinal cord injury patients regain function and hope - WGN-TV","headline":"New drug may help spinal cord injury patients regain function and hope - WGN","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxNel9IN3gtR19DUzhIb05paXpmbUxOM3VDc2xocGNONUlRSkNUX0J6OUEzM0xIX0RRbTlmRjBwWG0wLVlBT0Q4N3BfeHkxM192TkpZcXAwSHZVazNuMGV3LTRqSDNndmRoTWdWU0IzTWl5aXRCaG96Q29hdVYxMERvZ0x5WDBJZw?oc=5","date":"2026-01-12","type":"pipeline","source":"Northwestern Magazine","summary":"Pharma of the Future - Northwestern Magazine","headline":"Pharma of the Future","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAJBVV95cUxNZm9QcTlBbTdOUEpkLXNtaTc4RVY1amkteTFqWFROcmV1cFNHRU8zUFRRY3ZrbUpqT0xkRFdiWEthNHQtcndMeDdGVkc5TXpDVXozeFZsNXhIQ1dhcmNmYzJDT245Q3JKdUpObUZpUEx5aW1FVFFUcDkwSWxEbWZZZE93Z3Q2b2R0SXplNS00Z0JPV0pMdENhZ0hfWDEzR09xZ3BMeElmSlZkRW1NWk03U2xfTmFmRTdNY3NheHA0UWhUa09BNDZiX2hUMElwNXVYNDRPVXZLc3IyZnYxQ3FKbFZxUlVjNE9FRlQwcUdYRUsxZFFjVzAyNllybDVUdEJ0VFBqaFcyLU5WUlI3Q1RDM3ZMR2QxTnRadEltODBORzhtalJEcGtxQk9NWk9ITUZfcmRtM2dueVNpSUQtTGJYTg?oc=5","date":"2025-11-24","type":"trial","source":"BioSpace","summary":"NervGen Pharma Announces Expanded CONNECT SCI Study Data Demonstrating Unprecedented Durable Improvement in Function, Independence, and Quality of Life in Chronic Spinal Cord Injury - BioSpace","headline":"NervGen Pharma Announces Expanded CONNECT SCI Study Data Demonstrating Unprecedented Durable Improvement in Function, In","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxPTjFmckZrSjFHRFNha1RBREx4bnZjWVhNZnIwSWxCQ0xwRUotYlRhMDRzMzAya2RuNE5RMDd6b3VmLXpDeFNfVFJZVGdQRDRpdUF5Q0dpMmJhNVV0TnFGQjgtOEUxV3E1SHVYVXRycUF0NERKTXBqRURkVWVwUDhrQTVVUTRxZ2xRSVhOX0d3dTc0SGhnVHJR?oc=5","date":"2025-11-07","type":"pipeline","source":"CBS News","summary":"Pennsylvania man says experimental drug has helped him recover from cycling accident - CBS News","headline":"Pennsylvania man says experimental drug has helped him recover from cycling accident","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxNa2lJMG51aDJwLUNYdVBnY2dCSVZVbUt6Ym82Vnc2dWt0NlhtTGdFSnd5VFJITThUQjdoaTVSRm4ybWJmOS1MaWpSRzludlF2X21RX2Q3ajlKajRhdE1GT0FDbnN5RUFvWlZtNVF5anYwdVlkSHVVYXlOODFyajBHU3Z5NHpnSzhrcXRUVDFBT1Y5VkE4MWZ5eWJsalp2T25nQ1RFMFFsYUhMLThpVUpWeU5oTQ?oc=5","date":"2024-07-02","type":"trial","source":"Stockhouse","summary":"NervGen: Are amazing human trial results leaking out? | 2024-07-02 | Investing News - Stockhouse","headline":"NervGen: Are amazing human trial results leaking out? | 2024-07-02 | Investing News","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxNWkFqR1NBZnYxVFhTSVhnMnktVFVFbmRsMUVGY0ZqSl8tZldlMFhYRjJjT2pMN1lhYy1RYjZhQmxidDRtQ29ITUJ0MEdHOXlZaXJNM1M5WFFvMTludDM2NGJ0M3FZZU16ZjIzangwMkwyX3dGNHF1T280b21EcG90ZlYzd2RhY05DWmQ5UkZPbnNNamM3QWlNTjFn?oc=5","date":"2024-06-11","type":"pipeline","source":"Streetwise Reports","summary":"Is This Pharma Co. the Next Eli Lilly? - Streetwise Reports","headline":"Is This Pharma Co. the Next Eli Lilly?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxOOTAzeXN1V08taU5KWkFzOEtqbTRsZlBpZVgyUFJEMlJ0Q18tS0VXaFJSakFnWThYQUkzUS1zX280OUx4bmZta19yc2VrMWdJOHA5T0RFT25ZSzdYcm9JQm9zR0lIVWN4YXBxNnRPRGhNR01neTM5dUFTZTVFN0JRWmlHNGo1U2YxMy1EQkdnUQ?oc=5","date":"2024-02-15","type":"trial","source":"Yahoo Finance","summary":"NervGen Pharma on Track to Complete Enrollment, Deliver Data Readout in Phase 1b/2a Clinical Trial for NVG-291 in Spinal Cord Injury - Yahoo Finance","headline":"NervGen Pharma on Track to Complete Enrollment, Deliver Data Readout in Phase 1b/2a Clinical Trial for NVG-291 in Spinal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxOU2tWamdOenVyUkNBZW1vV3VlRTFNSjhOZlJtSEQ3TzVRVWtMZHQ4V2g2TVZlY3hiVUw2SEJzdU1wQW5LVGlpNGM0ZHF6RWpUVkNxZ0NaUlNCSnJTU2Z0OHVhaTl4OG4zQ0ppcUVhelRibmNySzZwbTdfbEIyY1FqYVlRV2toWEVjNkpTZld5TQ?oc=5","date":"2024-02-09","type":"pipeline","source":"Frontiers","summary":"Duration of Treatment Effect Using IncobotulinumtoxinA for Upper-limb Spasticity: A Post-hoc Analysis - Frontiers","headline":"Duration of Treatment Effect Using IncobotulinumtoxinA for Upper-limb Spasticity: A Post-hoc Analysis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxONFdrS0tIbkJmRXZkSDBlZUdSV1dwZzJZT1FlSVdDSzZta3E5ZTFab19jTmtMM3FuczVIbFJWcUVkcElCTFo4dWhyOTVHVHVieERMM0ZYS0luMUtvcGxlNVhHWDFHR3cydU5JamRXZC04S2lNQko3aWtCWUY4bDBJTXlwSERNLUE3Xzlv?oc=5","date":"2023-08-08","type":"regulatory","source":"Yahoo Finance","summary":"NervGen Pharma to Proceed with Landmark Phase 1b/2a Clinical Trial for NVG-291 in Spinal Cord Injury Having Completed FDA Review and Received IRB Approval - Yahoo Finance","headline":"NervGen Pharma to Proceed with Landmark Phase 1b/2a Clinical Trial for NVG-291 in Spinal Cord Injury Having Completed FD","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxQZkRZb3g1eUZwdy1UQkxsQjdQTUNOTVh2cThNYTJGRGc0aU40aWRtemdPR0ZlbXhTU19KdGFsZk1fS01vdFExWkNUR0J0Zk5YOWdUYkJxZnZ2RTVmTkgwLXlOOEdmREJ3LUhRak5HdXZtcGlxSlNpeXVmaWcxUWtuLXdJZjhyOFRkS2ZB?oc=5","date":"2023-03-09","type":"pipeline","source":"Drug Target Review","summary":"New self-powered drug delivery system - Drug Target Review","headline":"New self-powered drug delivery system","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2022-01-10","type":"trial","source":"Business Wire","summary":"NervGen Pharma Announces Intent to Conduct Groundbreaking Spinal Cord Injury Clinical Trial in Exclusive Partnership With Shirley Ryan AbilityLab, #1-Ranked Hospital in Physical Medicine & Rehabilitat","headline":"NervGen Pharma Announces Intent to Conduct Groundbreaking Spinal Cord Injury Clinical Trial in Exclusive Partnership Wit","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxNMkp3cE5ZVDR0SU5QSVRBVXAzN1lYZ1pxUUp2T3dxS0I5MUxCODJqNTZqVkhpa3J1RVhWOEtwTmJHR2ZMZFdhcW1rTXZkSjZCWC1DU1pzb28tRDRtYVlLQWo0T3ZTY3R5LV9UUUtuajE1OVpINU43dFRxd3ZfSGtVNjVsejVqTU9JOEhIS3VtWlVTVzNlU3EySE9ZSmNKSTQ2VEljYVhZMlg5Yndra0hLdHE3QzRHTkdTYkE?oc=5","date":"2021-01-28","type":"earnings","source":"wttw.com","summary":"Window To The World Communications, Inc. Announces Six New Trustees in Fiscal 2020 - wttw.com","headline":"Window To The World Communications, Inc. Announces Six New Trustees in Fiscal 2020","sentiment":"neutral"}],"patents":[],"drugCount":3,"phaseCounts":{"marketed":2,"phase_2":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}